Authors/Disclosures
|
Manuel Toledo
|
Manuel Toledo has nothing to disclose. |
|
Tobias Sejbaek, MD, PhD
(Esbjerg Hospital)
|
Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi. |
|
Anna Bjornsdottir, MD
(Duke Neurology)
|
No disclosure on file |
|
Michel Baulac, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Jens Leander
|
No disclosure on file |
|
Mark Milstein, MD, FAAN
(Montefiore Medical Center)
|
Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Marc De Backer, MD, FBCPM, MBA
|
No disclosure on file |
|
Melissa Brock
(SCHWARZ BIOSCIENCES, Inc.)
|
Melissa Brock has nothing to disclose. |
|
Konrad J. Werhahn, MD
(HCPS, NINDS, NIH)
|
No disclosure on file |